These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27562197)

  • 1. Neurocognitive performance following acute mephedrone administration, with and without alcohol.
    de Sousa Fernandes Perna EB; Papaseit E; Pérez-Mañá C; Mateus J; Theunissen EL; Kuypers K; de la Torre R; Farré M; Ramaekers JG
    J Psychopharmacol; 2016 Dec; 30(12):1305-1312. PubMed ID: 27562197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Pharmacology of Mephedrone in Comparison with MDMA.
    Papaseit E; Pérez-Mañá C; Mateus JA; Pujadas M; Fonseca F; Torrens M; Olesti E; de la Torre R; Farré M
    Neuropsychopharmacology; 2016 Oct; 41(11):2704-13. PubMed ID: 27206266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.
    Kuypers KP; Samyn N; Ramaekers JG
    Psychopharmacology (Berl); 2006 Sep; 187(4):467-75. PubMed ID: 16830130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance.
    Lamers CT; Ramaekers JG; Muntjewerff ND; Sikkema KL; Samyn N; Read NL; Brookhuis KA; Riedel WJ
    J Psychopharmacol; 2003 Dec; 17(4):379-87. PubMed ID: 14870949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function.
    Wilkinson CJ
    J Clin Psychiatry; 1995 Jul; 56(7):309-18. PubMed ID: 7615484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers.
    Dumont GJ; Schoemaker RC; Touw DJ; Sweep FC; Buitelaar JK; van Gerven JM; Verkes RJ
    J Psychopharmacol; 2010 Feb; 24(2):155-64. PubMed ID: 19164498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
    Leufkens TR; Lund JS; Vermeeren A
    J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers.
    Dumont GJ; Wezenberg E; Valkenberg MM; de Jong CA; Buitelaar JK; van Gerven JM; Verkes RJ
    Psychopharmacology (Berl); 2008 Apr; 197(3):465-74. PubMed ID: 18305926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly.
    Kerr JS; Fairweather DB; Mahendran R; Hindmarch I
    Int Clin Psychopharmacol; 1992 Nov; 7(2):101-8. PubMed ID: 1487621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol.
    Ramaekers JG; Kuypers KP
    Neuropsychopharmacology; 2006 May; 31(5):1048-55. PubMed ID: 16160704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute effects of MDMA and ethanol administration on electrophysiological correlates of performance monitoring in healthy volunteers.
    Spronk DB; Dumont GJ; Verkes RJ; De Bruijn ER
    Psychopharmacology (Berl); 2014 Jul; 231(14):2877-88. PubMed ID: 24770624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
    J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.
    Hernández-López C; Farré M; Roset PN; Menoyo E; Pizarro N; Ortuño J; Torrens M; Camí J; de La Torre R
    J Pharmacol Exp Ther; 2002 Jan; 300(1):236-44. PubMed ID: 11752122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine alters the behavioural and body temperature responses to mephedrone without causing long-term neurotoxicity in rats.
    Shortall SE; Green AR; Fone KC; King MV
    J Psychopharmacol; 2016 Jul; 30(7):698-706. PubMed ID: 27257032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory and mood during MDMA intoxication, with and without memantine pretreatment.
    de Sousa Fernandes Perna EB; Theunissen EL; Kuypers KP; Heckman P; de la Torre R; Farre M; Ramaekers JG
    Neuropharmacology; 2014 Dec; 87():198-205. PubMed ID: 24667166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected.
    Kuypers KP; Ramaekers JG
    Psychopharmacology (Berl); 2007 Jan; 189(4):557-63. PubMed ID: 16508761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol and cognitive function: assessment in everyday life and laboratory settings using mobile phones.
    Tiplady B; Oshinowo B; Thomson J; Drummond GB
    Alcohol Clin Exp Res; 2009 Dec; 33(12):2094-102. PubMed ID: 19740132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of the cognitive effects of acute alcohol with the morning after a normal night's drinking.
    McKinney A; Coyle K; Verster J
    Hum Psychopharmacol; 2012 May; 27(3):295-304. PubMed ID: 22499407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute behavioral effects of co-administration of mephedrone and MDMA in mice.
    Budzynska B; Michalak A; Frankowska M; Kaszubska K; Biała G
    Pharmacol Rep; 2017 Apr; 69(2):199-205. PubMed ID: 28073060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning.
    Stough C; King R; Papafotiou K; Swann P; Ogden E; Wesnes K; Downey LA
    Psychopharmacology (Berl); 2012 Apr; 220(4):799-807. PubMed ID: 22020992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.